Angioedema

Journal of the American Academy of Dermatology

Volumn 53, Issue 3, 2005, Pages 373-388

  Kaplan, Allen P ^a   Greaves, Malcolm W ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL SKIN CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; BRADYKININ; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C4; CYCLOOXYGENASE 1 INHIBITOR; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FC RECEPTOR; HISTAMINE; IBUPROFEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; KETOPROFEN; KETOROLAC; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MECLOFENAMIC ACID; MEFENAMIC ACID; MELOXICAM; MONTELUKAST; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PREDNISONE; SULINDAC; TOLMETIN; UNINDEXED DRUG;

ALCOHOL CONSUMPTION; ALLERGY; ANGIONEUROTIC EDEMA; ASCHER SYNDROME; CELLULITIS; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTACT ALLERGY; CROHN DISEASE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENZYMATIC DEGRADATION; EXERCISE; EYELID EDEMA; HUMAN; IMMUNOMODULATION; LYMPHEDEMA; LYMPHOMA; MAST CELL; MAST CELL DEGRANULATION; MELKERSSON ROSENTHAL SYNDROME; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PHOTODERMATOSIS; PRIORITY JOURNAL; REVIEW; SUPERIOR CAVA VEIN SYNDROME; URTICARIA;

ACUTE DISEASE; ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIAGNOSIS, DIFFERENTIAL; EMERGENCY TREATMENT; HUMANS; SKIN TESTS; URTICARIA;

EID: 23944464738     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.09.032     Document Type: Review

References (115)

1. M.W. Greaves, and F. Lawlor Angioedema: manifestations and management J Am Acad Dermatol 25 1991 155 165
2. J.L. Milton On giant urticaria Edinburgh Med J 22 1876 513 526
3. W. Osler Hereditary angio-neurotic edema Am J Med Sci 95 1888 362 367
4. V.H. Donaldson, and R.R. Evans A biochemical abnormality in hereditary angioneurotic edema: absence of inhibitor of C'1 esterase Am J Med 35 1963 37 44
5. R.H. Champion, S.O.B. Roberts, R.G. Carpenter, and J.H. Roger Urticaria and angioedema: a review of 554 patients Br J Dermatol 1969 588 597
6. R.A. Sabroe, P.T. Seed, D.M. Francis, R.M. Barr, A.K. Black, and M.W. Greaves Chronic idiopathic urticaria: comparison of clinical features of patients with or without anti-FcεR1 or anti-IgE autoantibodies J Am Acad Dermatol 40 1999 443 450
7. V.S. Beltrani Angioedema: some "new" thoughts regarding idiopathic angioedema M.W. Greaves A.P. Kaplan Urticaria and angioedema 2004 Marcel Dekker New York 421 439
8. M.R. Sanchez, M. Lee, J.A. Moy, and R. Ostreicher Ascher syndrome: a mimicker of acquired angioedema J Am Acad Dermatol 29 1993 650 651
9. M. Hannuksela Mechanisms in contact urticaria Clin Dermatol 15 1997 619 672
10. S. Miyagawa, Y. Takahashi, A. Nagai, Y. Yamamoto, A. Nakagawa, and K. Hori Angioedema in a neonate with IgG antibodies to parvovirus B19 following intrauterine parvovirus B19 infection Br J Dermatol 143 2000 428 430
11. E.M. Buchbinder, K.J. Bloch, and J. Moss Food dependent exercise-induced anaphylaxis J Am Med Assoc 250 1983 2973 2974
12. J.M. Kidd, S.H. Cohen, A.J. Sosman, and J.N. Fink Food dependent exercise induced anaphylaxis J Allergy Clin Immunol 71 1983 407 411
13. A. Romano, M. Di Fonsdo, F. Giuffreda, G. Papa, M.C. Artesani, and M. Viola Food dependent exercise induced anaphylaxis clinical and laboratory findings in 54 subjects Int Arch Allergy Appl Immunol 125 2001 264 272
14. A.J. Bircher Drug induced urticaria and angioedema caused by non-IgE mediated pathomechanisms Eur J Dermatol 9 1999 657 663
15. M.W. Greaves, and S.H. Hussain Drug-induced urticaria and angioedema: pathomechanisms and frequencies in a developing country and developed countries Int Arch Allergy Appl Immunol 128 2002 1 7
16. L. Juhlin Recurrent urticaria: clinical investigation of 330 patients Br J Dermatol 104 1981 369 381
17. A. Zembowicz, L. Mastalerz, L. Setkowicz, W. Radziszewski, and A. Szczeklik Safety of cyclo-oxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs Arch Dermatol 139 2003 1577 1582
18. D.L. Maxwell, B.A. Atkinson, and B.W. Spur Skin responses to histamine and leukotriene C4 D4 and E4 in patients with chronic idiopathic urticaria and in normal subjects J Allergy Clin Immunol 86 1990 759 765
19. C. Perez, M. Sanchez-Borges, and E. Capriles Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema J Allergy Clin Immunol 108 2001 1060 1061
20. G. Di Lorenzo, M.L. Pacor, P. Mansueto, A.E. Pelliteri, C.L. Bianco, and V. Ditta Randomised placebo-controlled trial comparing desloratidine and montelukast on monotherapy and desloratidine plus montelukast in combined therapy for chronic idiopathic urticaria J Allergy Clin Immunol 114 2004 619 625
21. Y. Ohnishi-Inoue, K. Mitsuya, and T. Horio Aspirin sensitive urticaria - provocation with a leukotriene receptor antagonist Br J Dermatol 138 1998 483 485
22. E.E. Slater, D.D. Merrill, H.A. Guess, P.J. Roylance, W.D. Cooper, and W.H.W. Inman Clinical profile of angioedema associated with angiotensin converting enzyme inhibition J Am Med Assoc 260 1988 967 970
23. N.J. Brown, M. Snowden, and M.R. Griffin Recurrent angiotensin-convertase enzyme inhibitor-associated angioedema J Am Med Assoc 278 1997 232 233
24. N.J. Brown, W.A. Ray, M. Snowden, and M.R. Griffin Black Americans have an increased rate of angiotensin convertase inhibitor-associated angioedema Clin Pharmacol Ther 60 1996 8 13
25. R. Agah, V. Bandi, and K.K. Gunturpalli Angioedema: the role of ACE inhibitors and factors associated with a poor outcome Intensive Care Med 23 1999 793 796
26. E.C. Pigman, and J.L. Scott Angioedema in the emergency department: the impact of angiotensin converting enzyme inhibitors Am J Emerg Med 11 1993 350 354
27. E.G. Erdos Conversion of angiotensin I to angiotensin II Am J Med 60 1976 749 759
28. J. Nussberger, M. Cugno, C. Amstutz, M. Cicardi, A. Pellacani, and A. Agostini Plasma bradykinin in angioedema Lancet 351 1998 1693 1697
29. M.W. Greaves, and S. Shuster Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine J Physiol 193 1967 255 267
30. F.H. Messerli, and J. Nussberger Vasopeptide inhibition and angioedema Lancet 356 2000 608 609
31. M.A. Cascieri, H.G. Bull, and R.A. Mumford Carboxy-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422 Mol Pharmacol 25 1984 287 293
32. K.P. Mathews, M. Pan, M.J. Gardner, and T. Hugli Familial carboxypeptidase N deficiency Ann Intern Med 93 1980 443 445
33. 9-bradykinin by angiotensin converting enzyme Biochem Pharmacol 35 1986 1951 1956
34. I. Sheikh, and A.P. Kaplan Studies of the digestion of bradykinin, lysyl bradykinin, and kinin degradation products by carboxypeptidases A, B, and N Biochem Pharmacol 35 1986 1957 1963
35. R.A. Sabroe, and A.K. Black Angiotensin converting enzyme (ACE) inhibitors and angioedema Br J Dermatol 136 1997 153 158
36. M. Matsumura, K. Haruki, K. Kajinami, and T. Takada Angioedema likely related to angiotensin converting enzyme inhibitors Int Med 32 1993 424 446
37. R.L. Jacobs, L.J. Hoberman, and H.M. Goldstein Angioedema of the small bowel caused by an angiotensin converting enzyme inhibitor Am J Gastroenterol 89 1994 127 128
38. Y. Oike, Y. Ogata, and D. Higashi Fatal angioedema associated with enalapril Int Med 32 1993 308 310
39. T. Thompson, and M.A. Smith-Frable Drug-induced life-threatening angioedema revisited Laryngoscope 103 1993 10 12
40. N. Orfan, R. Patterson, and M.S. Dykewicz Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema J Am Med Assoc 264 1990 1278 1289
41. A.K. Black Physical urticarias and cholinergic urticaria M.W. Greaves A.K. Kaplan Urticaria and angioedema 2004 Marcel Dekker New York 171 214
42. M.W. Greaves Chronic urticaria as a new autoimmune disease M. Hertl Autoimmune diseases of the skin 2001 Springer, Wien New York 283 302
43. M.A. Kozel, J.R. Mekkes, P.M. Bossuyt, and J.D. Bos Natural course of physical and chronic urticaria and angioedema in 220 patients J Am Acad Dermatol 45 2001 387 391
44. E. Nettis, A. Pannofino, C. D'Aprile, A. Ferrannini, and A. Tursi Clinical and etiological aspects in urticaria and angioedema Br J Dermatol 148 2003 501 506
45. W.R. Heymann Chronic urticaria and angioedema associated with thyroid autoimmunity: review and therapeutic implications J Am Acad Dermatol 40 1999 229 232
46. A. Leznoff, R.G. Josse, J. Denburg, and J. Dolovich Association of chronic urticaria and angioedema with thyroid immunity Arch Dermatol 119 1983 636 640
47. B.L. Gruber, M. Baeza, M. Marchese, B. Agnello, and A.P. Kaplan Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes J Invest Dermatol 90 1988 213 217
48. M. Hide, D.M. Francis, C.E.H. Grattan, J. Hakimi, J.P. Kochan, and M.W. Greaves Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria N Engl J Med 328 1993 1599 1604
49. E. Fiebiger, D. Maurer, H. Holub, and G. Stingl Serum IgG autoantibodies directed against the alpha chain of Fc epsilon R1: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients J Clin Invest 96 1995 2606 2612
50. N. Niimi, D.M. Francis, F. Kermani, B.F. O'Donnell, M. Hide, and A.K. Black Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria J Invest Dermatol 106 1996 1001 1010
51. M. Ferrer, J.P. Kinet, and A.P. Kaplan Comparative studies of functional and binding assays for IgG ani-Fc epsilon R1 alpha (alpha subunit) in chronic urticaria J Allergy Clin Immunol 101 1998 672 676
52. M. Ferrer, K. Nakazawa, and A.P. Kaplan Complement dependence of histamine release in chronic urticaria J Allergy Clin Immunol 104 1999 169 172
53. Y. Kikuchi, and A.P. Kaplan A role for C5a augmenting IgG dependent histamine release from basophils in chronic urticaria J Allergy Clin Immunol 109 2002 114 118
54. C.E.H. Grattan, D.M. Francis, R.J. Barlow, M.W. Greaves, and N.G.P. Slater Plasmapheresis for severe unremitting chronic urticaria Lancet 339 1992 1078 1080
55. C.E.H. Grattan, B.F. O'Donnell, and D.M. Francis Randomized double blind study of cyclosporin in chronic idiopathic urticaria Br J Dermatol 143 2000 365 372
56. B.F. O'Donnell, R.M. Barr, and A.K. Black Intravenous immunoglobulin in chronic autoimmune urticaria Br J Dermatol 138 1998 101 106
57. J. Claveau, A. Lavoie, C. Bunet, P.M. Bedard, and J. Hebert Comparison of histamine releasing factor recovered from skin and peripheral blood mononuclear cells of patients with chronic idiopathic urticaria Ann Allergy Asthma Immunol 77 1996 475 479
58. R. Confino-Cohen, D. Aharoni, A. Goldberg, I. Gurevitch, A. Bachs, and M. Weiss Evidence for aberrant regulation of the P21 Ras pathway - PMBC's of patients with chronic idiopathic urticaria J Allergy Clin Immunol 109 2002 349 356
59. R.A. Sabroe, E. Poon, G. Orchard, D. Lane, D.M. Francis, and R.M. Barr Cutaneous inflammatory infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεR1 or anti-IgE autoantibodies J Allergy Clin Immunol 103 1999 484 493
60. R.A. Sabroe, C.E.M. Grattan, D.M. Francis, R.M. Barr, A. Kobza Black, and M.W. Greaves The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria Br J Dermatol 140 1999 446 452
61. C.E.H. Grattan, D. Walpole, D.M. Francis, N. Niimi, G. Dootson, and S. Elder Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to histamine releasing activity Clin Exp Allergy 27 1997 1417 1424
62. Y. Kikuchi, T. Fann, and A.P. Kaplan Antithyroid antibodies in chronic urticaria and angioedema J Allergy Clin Immunol 112 2003 218
63. O'Donnell BF, Francis DM, Swana BT, Seed PT, Black AK, Greaves MW. Thyroid autoimmunity in chronic utricaria. Br J Dermatol 2005. In press.
64. G. Michaelsson, and L. Juhlin Urticaria induced by preservatives and dye additives in food and drugs Br J Dermatol 88 1978 525 532
65. H.M.G. Doeglas Reactions to aspirin and food additives in patients with chronic urticaria including physical urticarias Br J Dermatol 93 1975 135 144
66. K.P. Mathews Urticaria and angioedema J Allergy Clin Immunol 72 1983 1 14
67. A.P. Kaplan Chronic urticaria and angioedema N Engl J Med 946 2002 275 279
68. J.E. Gach, R.A. Sabroe, and M.W. Greaves Methotrexate-responsive chronic idiopathic urticaria: a report of two cases Br J Dermatol 145 2001 340 343
69. H. Weidenbach, K.H. Beckh, M.M. Lerch, and G. Adler Precipitation of hereditary angioedema by infectious mononucleosis Lancet 342 1993 934 935
70. M. Rais, J. Unzeitig, and J.A. Grant Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection J Allergy Clin Immunol 103 1999 713 714
71. H. Farkas, G. Fust, B. Feketi, I. Karadi, and L. Varga Eradication of Helicobacter pylori and improvement of hereditary angioneurotic edema Lancet 358 2001 1695 1696
72. G.J. Gleich, A.L. Schroeter, and P. Marcoux Episodic angioedema associated with eosinophilia N Engl J Med 310 1984 1621 1626
73. P. Lassalle, P. Gosset, V. Gruart, and M. Capron Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia Clin Exp Immunol 82 1990 38 43
74. J.J. Wiesnieski, A.N. Baer, J. Christensen, T.R. Cupps, D.N. Flagg, and J.V. Jones Hypocomplementemic urticarial vasculitis syndrome: clinical and serological findings in 18 patients Medicine 74 1995 24 41
75. M. Cicardi, L. Bergamaschini, B. Marasini, G. Boccasini, A. Tucci, and A. Agostoni Hereditary angioedema: an appraisal of 104 cases Am J Med Sci 284 1982 2 9
76. A. Agostoni, and M. Cicardi Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients Medicine (Baltimore) 71 1992 206 215
77. T. Fields, B. Ghebrehiwet, and A.P. Kaplan Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin J Allergy Clin Immunol 72 1983 54 60
78. J.G. Curd, L.F. Prograis Jr., and C.G. Cochrane Detection of active kallikrein in induced blister fluids of hereditary angioedema patients J Exp Med 152 1980 742 747
79. R. Zahedi, J.J. Bissler, A.E. Davis III, C. Andreadis, and J.J. Wisnieski Unique C1 inhibitor dysfunction in a kindred without angioedema II: identification of a Ala 443→ Val substitution and functional analysis of the recombinant mutant protein J Clin Invest 95 1995 1299 1305
80. R. Zahedi, and J. Wisnieski Davis AE III. Role of the P2 residue of complement 1 inhibitor (Ala 443) in determination of target protease specificity: inhibition of complement and contact proteases J Immunol 159 1997 983 988
81. M. Cugno, M. Cicardi, R. Coppola, and A. Agostini Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1 inhibitor deficiencies Immunopharmacology 33 1996 361 364
82. J. Nussberger, M. Cugno, M. Cicardi, and A. Agostoni Local bradykinin generation in hereditary angioedema J Allergy Clin Immunol 104 1999 1321 1322
83. M. Quastel, R. Harrison, M. Cicardi, C.A. Alper, and F.S. Rosen Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioedema J Clin Invest 71 1983 1041 1046
84. J. Kramer, Y. Katz, F.S. Rosen, A.E. Davis III, and R.C. Strunk Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema J Clin Invest 87 1991 1614 1620
85. J. Kramer, R.S. Rosen, H.R. Colter, K. Fajezy, and A.C. Strunk Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema J Clin Invest 91 1993 1258 1262
86. M. Tosi Molecular genetics of C1 inhibitor Immunobiology 199 1998 358 365
87. B. Laurell, and U. Martensson C1 inactivator protein complexed with albumen in plasma from a patient with angioneurotic edema Eur J Immunol 1 1971 146 169
88. J. Yip, and W.J. Cunliffe Hormonally exacerbated hereditary angioedema Australas J Dermatol 33 1992 35 38
89. T.J. Shah, W.O. Knowles, and S.J. McGeady Hereditary angioedema with recurrent abdominal pain and ascites J Allergy Clin Immunol 96 1995 259 261
90. C.M. Brickman, G.C. Tsokos, J.E. Balow, T.J. Lawley, M. Santaella, and C.H. Hammer Immunoregulatory disorders associated with hereditary angioedema J Allergy Clin Immunol 77 1986 749 757
91. W. Perkins, G.I. Stables, and R.S. Lever Protein S deficiency in lupus erythematosus secondary to hereditary angioedema Br J Dermatol 130 1994 381 384
92. W. Perkins, I. Downie, M. Keefe, and M. Chisolm Cutaneous necrosis in pregnancy secondary to activated protein C resistance in hereditary angioedema J R Soc Med 88 1995 229 230
93. M.R. Judge, K.M. Watson, and M.W. Greaves C1 esterase inhibitor concentrate in the management of hereditary angioedema J Dermatol Treat 4 1993 95 97
94. A.T. Waytes, F.S. Rosen, and M.M. Frank Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate N Engl J Med 334 1996 1630 1634
95. W.B. Spaulding Methyl testosterone therapy for hereditary episodic edema (hereditary angioneurotic edema) Ann Intern Med 53 1960 739 744
96. A.L. Sheffer, D.T. Fearon, K.F. Austen, and F.S. Rosen Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema J Allergy Clin Immunol 60 1977 33 40
97. M. Cicardi, L. Bergamaschini, A. Tucci, M. Galdinali, G. Sacchi, and A. Agostoni Morphological evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives J Allergy Clin Immunol 72 1983 294 298
98. A.P. Warin, M.W. Greaves, M. Gatecliffe, D.M. Williamson, and R.P. Warin Treatment of hereditary angioedema by low dose attenuated androgens: disassociation of clinical response from levels of C1 esterase inhibitor and C4 Br J Dermatol 103 1980 405 409
99. K. Bork, S.-E. Barnstedt, P. Koch, and H. Traupe Hereditary angioedema with normal C1 INH activity in women Lancet 356 2000 213 217
100. K.E. Binkley, and A. Davis Clinical biochemical and genetic characterization of a novel oestrogen dependent inherited form of angioedema J Allergy Clin Immunol 106 2000 546 550
101. J.J. Costanzi, C.A. Coltman, and V.H. Donaldson Activation of complement by a monoclonal cryoglobulin associated with cold urticaria J Lab Clin Med 74 1969 902 910
102. J.R. Caldwell, S. Ruddy, P. Schur, and K.F. Austen Acquired C1 inhibitor deficiency in lymphosarcoma Clin Immunol Immunopathol 1 1972 39 52
103. G. Hauptmann, J.M. Lang, M.L. North, F. Oberling, G. Mayer, and P.J. Lachmann Acquired C1 inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities Blut 32 1976 195 206
104. A.D. Schreiber, B. Zweiman, P. Atkins, F. Goldwein, G. Pietra, and B. Alkinson Acquired angioedema with lymphoproliferative disorder association of C1 inhibitor deficiency with cellular abnormality Blood 48 1976 567 580
105. R.S. Geha, I. Quinti, K.F. Austen, M. Cicardi, A. Sheffa, and F.S. Rosen Acquired C1 inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulin N Engl J Med 312 1985 534
106. V.H. Donaldson, E.V. Hess, and P.J. McAdams Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema Ann Intern Med 86 1977 312 313
107. S.H. Cohen, S.M. Koethe, F. Kozin, G. Rodey, J.A. Arkins, and J.N. Fink Acquired angioedema associated with rectal carcinoma and its response to danazol therapy J Allergy Clin Immunol 62 1978 217 221
108. J. Jackson, R.B. Simn, A. Whelan, and C. Feighery An IgG autoantibody which inactivates C1 inhibitor Nature 323 1986 722 724
109. J. Alsenz, K. Bork, and M. Loos Autoantibody-mediated acquired deficiency of C1 inhibitor N Engl J Med 313 1987 1360 1366
110. A. Malbran, C.H. Hammer, M.M. Frank, and L.F. Fries Acquired angioedema: observations on the mechanisms of action of autoantibodies directed against C1 esterase inhibitor J Allergy Clin Immunol 81 1988 1199 1204
111. J. Jackson, R.B. Sim, K. Qhaley, and C. Feighery Autoantibody facilitated cleavage of C1 inhibitor in autoimmune angioedema J Clin Invest 83 1989 698 707
112. S. He, R.B. Sim, and K. Whaley Mechanism of action of anti C1 inhibitor autoantibodies: prevention of the formation of stable C1S-C1 INH complexes Mol Med 4 1998 119 128
113. M. Cicardi, A. Beretta, M. Colombo, D. Gioffre, M. Cugno, and A. Agostoni Relevance of lymphoproliferative disorders and anti C1 inhibitor autoantibodies in acquired angioedema Clin Exp Immunol 106 1996 475 480
114. A. Chevailler, G. Orland, D. Ponard, M. Pernollet, F. Carrere, and G. Renser C1 inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema J Allergy Clin Immunol 97 1996 998 1008
115. M. Cugno, M. Cicardi, and A. Agostoni Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid J Allergy Clin Immunol 93 1994 870 876